Health Care: Drugs

IDEXX Laboratories Inc (IDXX: NASDAQ)

$164.05 4.65 | 2.92%
04/24/15 - 04:00 PM ET
Company Income Statement
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Sales 1.49B 1.38B 1.29B 1.22B
Cost of Sales 610.80M 566.34M 541.78M 523.98M
Gross Operating Profit 875.00M 810.71M 751.56M 694.71M
Selling, General, and Administrative Expenses 457.60M 401.35M 354.57M 334.24M
Research & Development 98.26M 88.00M 82.01M 76.04M
Operating Income before D & A (EBITDA) 319.14M 321.36M 314.97M 284.43M
Depreciation & Amortization 58.89M 54.60M 52.41M 48.20M
Interest Income 1.73M 1.88M 1.90M 1.74M
Other Income - Net 0.00 0.00 0.00 0.00
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) 261.98M 268.65M 264.46M 237.97M
Interest Expense 15.43M 5.39M 3.85M 3.55M
Pre-Tax Income 246.56M 263.26M 260.62M 234.42M
Income Taxes 64.60M 75.47M 82.33M 72.67M
Minority Interest 45.00K -6.00K 20.00K -32.00K
Net Income From Continuing Operations 181.95M 187.79M 178.29M 161.75M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations 181.95M 187.79M 178.29M 161.75M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income 181.91M 187.80M 178.27M 161.79M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
181.95M 187.79M 178.29M 161.75M
Preferred Dividends
Net Income Available To Common 181.95M 187.79M 178.29M 161.75M
Basic EPS from Continuing Ops. 3.63 3.53 3.24 2.85
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations 3.63 3.53 3.24 2.85
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total 3.63 3.53 3.24 2.85
Basic Normalized Net Income/Share 3.63 3.53 3.24 2.85
EPS fr Continuing Ops. 3.58 3.48 3.17 2.78
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. 3.58 3.48 3.17 2.78
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total 3.58 3.48 3.17 2.78
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
3.58 3.48 3.17 2.78
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with IDXX

Latest IDXX Headlines from TheStreet

More Financial News for IDXX

Press Releases for IDXX

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter